Männel, Daniela N. and Kist, A. and Ho, A. D. and Räth, U. and Reichardt, P. and Wiedenmann, B. and Schlick, E. and Kirchner, H.
Tumour necrosis factor production and natural killer cell activity in peripheral blood during treatment with recombinant tumour necrosis factor.
British journal of cancer 60 (4), pp. 585-588.
Tumour necrosis factor (TNF) has been found to be an important immunomodulator. Among other functions TNF activates natural killer (NK) cells and stimulates monocytes/macrophages in an autocrine fashion. TNF production and NK activity in peripheral blood mononuclear cells were determined in a clinical phase I study in which recombinant human (rh) TNF was administered as a continuous infusion ...
Export bibliographical data
|Institutions:||Medicine > Lehrstuhl für Immunologie|
|Killer Cells, Natural/drug effects||MESH|
|Recombinant Proteins/therapeutic use||MESH|
|Tumor Necrosis Factor-alpha/therapeutic use||MESH|
|Dewey Decimal Classification:||600 Technology > 610 Medical sciences Medicine|
|Refereed:||Yes, this version has been refereed|
|Created at the University of Regensburg:||Unknown|
|Deposited on:||20 Jun 2011 06:24|
|Last modified:||13 Mar 2014 17:33|